NDSN

Nordson Corp

Add to Watchlist

Advanced Chart

215.760

-4.45(-2.021%)1D

Overview
Forecast
Valuation
Earnings

Line

Candle

YTD

High

219.960

Open

219.900

VWAP

Vol

398.85K

Mkt Cap

12.19B

Low

214.825

Amount

EV/EBITDA(TTM)

18.18

Total Shares

57.27M

14.55B

EV/OCF(TTM)

26.96

P/S(TTM)

4.68

Nordson Corporation is a precision technology company. The Company engineers, manufactures and markets differentiated products and systems used for precision dispensing, applying and controlling adhesives, coatings, polymers, sealants, biomaterials, and other fluids, to test and inspect for quality, and to treat and cure surfaces and various medical products. Its segments include Industrial Precision Solutions, Medical and Fluid Solutions and Advanced Technology Solutions. The Industrial Precision Solutions segment delivers dispensing and material processing technology to diverse end markets. This segment serves the consumer durables, non-durables, agricultural and industrial markets. The Medical and Fluid Solutions segment includes fluid management solutions for medical, high-tech industrial and other diverse end markets. The Company’s Advanced Technology Solutions segment integrates its product technologies into the progressive stages of a customer’s production processes.

Market Estimates

Earnings Estimates

Revenue

YoY Chg

EPS

YoYChg

FY2025Q3

FY2025Q4

FY2026Q1

723.93M

+9.42%

2.637

+9.4%

773.20M

+3.86%

2.924

+5.19%

661.00M

+7.41%

2.342

+13.7%

Estimates Revision

The market is revising Upward the revenue expectations for Nordson Corporation (NDSN) for FY2025, with the revenue forecasts being adjusted by 0.88% over the past three months. During the same period, the stock price has changed by 13.82%.

Revenue Estimates for FY2025

Revise Upward

+0.88%

In Past 3 Month

EPS Estimates for FY2025

Revise Upward

+1.44%

In Past 3 Month

Stock Price

Go Up

+13.82%

In Past 3 Month

9 Analyst Rating

18.48% Upside

Wall Street analysts forecast NDSN stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for NDSN is 255.63 USD with a low forecast of 230.00 USD and a high forecast of 285.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

5 Buy

4 Hold

0 Sell

Moderate Buy

18.48% Upside

Current: 215.760

Low

230.00

Averages

255.63

High

285.00

18.48% Upside

Current: 215.760

Low

230.00

Averages

255.63

High

285.00

Wolfe Research

initiated

2025-06-19

Reason

Wolfe Research

Price Target

2025-06-19

initiated

Reason

Wolfe Research initiated coverage of Nordson with a Peer Perform rating.

Wolfe Research

Peer Perform

initiated

2025-06-19

Reason

Wolfe Research

Price Target

2025-06-19

initiated

Peer Perform

Reason

As previously reported, Wolfe Research initiated coverage of Nordson with a Peer Perform rating and no price target. Nordson has "historically been viewed in the industrial compounder bucket," but questions around the M&A flywheel and cyclical headwinds in medical and semi markets have caused the stock to lag, the analyst tells investors. While the firm believes Nordson has "much of the internal DNA of an industrial compounder," it would like to see more evidence of a smoothly spinning M&A flywheel, noting that it sees a a $172-$275 bear/bull spread. With Street EPS estimates for FY25/26 having reset about 8% lower over the past 15 months, estimates are "now in a pretty good spot," though not a low bar, the analyst added.

Vertical Research

NULL -> Hold

initiated

$245

2025-06-18

Reason

Vertical Research

Price Target

$245

2025-06-18

initiated

NULL -> Hold

Reason

Vertical Research initiated coverage of Nordson with a Hold rating and $245 price target.

Oppenheimer

Christopher Glynn

Perform

Outperform

upgrade

$260

2025-05-30

Reason

Oppenheimer

Christopher Glynn

Price Target

$260

2025-05-30

upgrade

Perform

Outperform

Reason

Oppenheimer analyst Christopher Glynn upgraded Nordson to Outperform from Perform with a $260 price target. The company is emerging from a "relatively nettlesome layering of cyclical headwinds," the analyst tells investors in a research note. The firm says Nordson's fiscal Q3 is positioned for positive organic after eight quarters negative. It believes the company is now positioned for compound organic growth, with "sturdy positioning" across end markets, cyclical headwinds largely abated, portfolio tuning underappreciated, and an increasingly focused cost structure.

Baird

Michael Halloran

Neutral

maintain

$241 -> $245

2025-05-30

Reason

Baird

Michael Halloran

Price Target

$241 -> $245

2025-05-30

maintain

Neutral

Reason

Baird analyst Michael Halloran raised the firm's price target on Nordson to $245 from $241 and keeps a Neutral rating on the shares. The firm updated its model to reflect stabilizing estimates and where its order and backlog trajectory remains a positive.

Keybanc

Jeffrey Hammond

Buy

Maintains

$260 → $230

2025-04-08

Reason

Keybanc

Jeffrey Hammond

Price Target

$260 → $230

2025-04-08

Maintains

Buy

Reason

KeyBanc lowered the firm's price target on Nordson to $230 from $260 and keeps an Overweight rating on the shares. Although companies across the Industrial universe took different approaches to the tariff impacts on guidance and the firm previously felt outlooks generally embedded some prudent conservatism, Liberation Day tariffs proved to be much more meaningful than anticipated and have created significant uncertainty for capital investment near-term. As such, KeyBanc sees risk to both the top- and margin-line updates on a go-forward basis.

See All Ratings

Valuation Metrics

The current forward P/E ratio for Nordson Corp (NDSN.O) is 20.81, compared to its 5-year average forward P/E of 25.05. For a more detailed relative valuation and DCF analysis to assess Nordson Corp 's fair value, click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.

Undervalued

5Y Average PE

25.05

Current PE

20.81

Overvalued PE

27.91

Undervalued PE

22.18

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.

Undervalued

5Y Average EV/EBITDA

17.55

Current EV/EBITDA

15.90

Overvalued EV/EBITDA

19.12

Undervalued EV/EBITDA

15.98

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.

Undervalued

5Y Average PS

4.97

Current PS

4.31

Overvalued PS

5.43

Undervalued PS

4.52